APA

Molokie R., Lavelle D., Gowhari M., Pacini M., Krauz L., Hassan J., Ibanez V., Ruiz M. A., Ng K. P., Woost P., Radivoyevitch T., Pacelli D., Fada S., Rump M., Hsieh M., Tisdale J. F., Jacobberger J., Phelps M., Engel J. D., Saraf S., Hsu L. L., Gordeuk V., DeSimone J. & Saunthararajah Y. (20170914). Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study. : PLoS medicine.

Chicago

Molokie Robert, Lavelle Donald, Gowhari Michel, Pacini Michael, Krauz Lani, Hassan Johara, Ibanez Vinzon, Ruiz Maria A, Ng Kwok Peng, Woost Philip, Radivoyevitch Tomas, Pacelli Daisy, Fada Sherry, Rump Matthew, Hsieh Matthew, Tisdale John F, Jacobberger James, Phelps Mitch, Engel James Douglas, Saraf Santhosh, Hsu Lewis L, Gordeuk Victor, DeSimone Joseph and Saunthararajah Yogen. 20170914. Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study. : PLoS medicine.

Harvard

Molokie R., Lavelle D., Gowhari M., Pacini M., Krauz L., Hassan J., Ibanez V., Ruiz M. A., Ng K. P., Woost P., Radivoyevitch T., Pacelli D., Fada S., Rump M., Hsieh M., Tisdale J. F., Jacobberger J., Phelps M., Engel J. D., Saraf S., Hsu L. L., Gordeuk V., DeSimone J. and Saunthararajah Y. (20170914). Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study. : PLoS medicine.

MLA

Molokie Robert, Lavelle Donald, Gowhari Michel, Pacini Michael, Krauz Lani, Hassan Johara, Ibanez Vinzon, Ruiz Maria A, Ng Kwok Peng, Woost Philip, Radivoyevitch Tomas, Pacelli Daisy, Fada Sherry, Rump Matthew, Hsieh Matthew, Tisdale John F, Jacobberger James, Phelps Mitch, Engel James Douglas, Saraf Santhosh, Hsu Lewis L, Gordeuk Victor, DeSimone Joseph and Saunthararajah Yogen. Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study. : PLoS medicine. 20170914.